In:
Haematologica, Ferrata Storti Foundation (Haematologica), Vol. 107, No. 4 ( 2021-05-06), p. 921-932
Kurzfassung:
DIS3 gene mutations occur in roughly 10% of patients with multiple myeloma (MM); furthermore, DIS3 expression can be affected by monosomy 13 and del(13q), which occur in approximately 40% of MM cases. Despite several reports on the prevalence of DIS3 mutations, their contribution to the pathobiology of MM remains largely unknown. We took advantage of the large public CoMMpass dataset to investigate the spectrum of DIS3 mutations in MM and its impact on the transcriptome and clinical outcome. We found that the clinical relevance of DIS3 mutations strictly depended on the co-occurrence of del(13q). In particular, bi-allelic DIS3 lesions significantly affected progression-free survival, independently of other predictors of poor clinical outcome, while mono-allelic events mostly affected overall survival. As expected, DIS3 mutations affect the MM transcriptome involving cellular processes and signaling pathways associated with RNA metabolism, and the deregulation of a large number of long non-coding RNA, among which we identified five distinct transcripts as independent predictors of poorer overall survival and nine of worse progression-free survival, with two (AC015982.2 and AL445228.3) predicting both unfavorable outcomes. These findings strongly prompt further studies investigating the relevance of these long non-coding RNA in MM.
Materialart:
Online-Ressource
ISSN:
1592-8721
,
0390-6078
DOI:
10.3324/haematol.2021.278342
Sprache:
Unbekannt
Verlag:
Ferrata Storti Foundation (Haematologica)
Publikationsdatum:
2021
ZDB Id:
2186022-1
ZDB Id:
2030158-3
ZDB Id:
2805244-4
